<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis C virus (HCV) infection is one of the most serious complications of transfusion therapy in the thalassemia and Sickle Cell Disease (SCD) population receiving transfusions before 1990; in fact, since the year 1990 serological tests were made available for detect infections in blood donors.</p>
